Compare MFIN & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MFIN | SENS |
|---|---|---|
| Founded | 1995 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.4M | 252.5M |
| IPO Year | 1996 | N/A |
| Metric | MFIN | SENS |
|---|---|---|
| Price | $10.48 | $6.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $12.00 | ★ $25.58 |
| AVG Volume (30 Days) | 44.1K | ★ 362.4K |
| Earning Date | 10-29-2025 | 11-05-2025 |
| Dividend Yield | ★ 4.57% | N/A |
| EPS Growth | ★ 1.06 | N/A |
| EPS | ★ 1.71 | N/A |
| Revenue | ★ $338,783,000.00 | $29,298,000.00 |
| Revenue This Year | N/A | $59.55 |
| Revenue Next Year | $5.83 | $70.49 |
| P/E Ratio | $6.14 | ★ N/A |
| Revenue Growth | 15.53 | ★ 31.94 |
| 52 Week Low | $7.71 | $5.25 |
| 52 Week High | $10.98 | $28.00 |
| Indicator | MFIN | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 56.02 | 48.13 |
| Support Level | $10.35 | $6.03 |
| Resistance Level | $10.85 | $6.44 |
| Average True Range (ATR) | 0.27 | 0.35 |
| MACD | -0.00 | -0.13 |
| Stochastic Oscillator | 62.91 | 17.91 |
Medallion Financial Corp is a finance company that originates and services loans in various industries. The five operating segments are, (1) recreation, (2) home improvement, (3) commercial, (4) taxi medallion, and (5) strategic partnership loans. The company generates maximum revenue from the Recreation segment.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.